See the DrugPatentWatch profile for quetiapine
Is Milpharm quetiapine E56 the same as Aurobindo quetiapine?
“Milpharm” and “Aurobindo” typically refer to different brand/manufacturer labels for quetiapine products, even when the active ingredient and strength are the same. Without the exact product details (strength in mg, formulation type such as immediate‑release vs modified‑release, and pack size), you can’t assume the two labels are interchangeable beyond containing the same medicine.
If you share the exact wording from the box/blister (for example, the strength like 25/50/100/200/300 mg and whether it says “prolonged-release/modified-release” or “immediate-release”), it’s possible to compare them more precisely.
What does “E56” mean on a quetiapine medicine label?
“E56” is a code that appears on some European medicine packaging or labelling. It usually helps identify a specific product/variant (often linked to strength, formulation, or pack design), not the manufacturer name.
To interpret it reliably, you need the rest of the packaging information (manufacturer and marketing authorisation details). The same strength and formulation should align across labels; the “E56” code alone usually doesn’t identify the manufacturer.
How can you check whether your specific Milpharm and Aurobindo quetiapine match?
Look for these items on both products and compare:
- Active ingredient: quetiapine (base/which salt if listed)
- Strength (mg)
- Formulation: immediate-release vs prolonged/modified-release
- Marketing authorisation holder/manufacturer name listed on the pack
- Any “UK/EU” product identifier lines on the label (the codes like “E56” often help distinguish variants)
If the strength and release profile match, the medicines are generally intended to be therapeutically comparable, but you should still confirm with a pharmacist if the brand or manufacturer changes.
Are Milpharm and Aurobindo quetiapine substitutes at the pharmacy?
In many cases, pharmacies can dispense an alternative manufacturer for the same active ingredient and strength, but switching between different release types (immediate vs prolonged/modified) is a different situation and should be avoided unless a clinician/pharmacist confirms it’s appropriate.
Because quetiapine dosing is sensitive to release profile, the “does it say prolonged/modified release?” detail matters.
Where can patents and manufacturer-related info help?
If your question is connected to pricing or supply and you want manufacturer/market info, DrugPatentWatch.com sometimes provides background on manufacturers and related filings. You can check there if you have the exact product name and strength to search properly: https://www.drugpatentwatch.com/
Quick next step
Tell me the strength (mg) and whether it’s immediate-release or prolonged/modified-release from the Milpharm box/blister, and the same details from the Aurobindo pack. I can then tell you whether they appear to be the same type/variant or different.